Another scenario that has not been mentioned is that NEU does the phase 3 trial alone!
It's a possibility if pharma deals that may be on the table are not satisfactory to Neu board .
We could easily offer 15% of share registry to institutional investors at $ 3 plus and raise $45 to $50 million to finance a 6 month ph 3 trial.
This might seem unlikely ATM but it can occur if deals forth coming from big pharma are not as high as some here think. Going it alone with a positive ph 3 Retts result would value NEU in the billions.
NEU Price at posting:
0.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)